Back
Exicure, Inc. 10K Form
Sell
49
XCUR
Exicure, Inc.
Last Price:
$6.00
Seasonality Move:
-0.79%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive XCUR News And Ratings
See the #1 stock for the next 7 days that we like better than XCUR
XCUR Financial Statistics
Sales & Book Value
| Annual Sales: | $500K |
|---|---|
| Cash Flow: | $-3.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.09 |
| Price / Book: | 5.45 |
Profitability
| EPS (TTM): | -1.50510 |
|---|---|
| Net Income (TTM): | $-9.2M |
| Gross Margin: | $-324K |
| Return on Equity: | -130.03% |
| Return on Assets: | -57.41% |
Exicure, Inc. Earnings Forecast
Key Exicure, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for XCUR is -64.80%.
-
The Selling, General & Administrative Expenses for XCUR have been equal to 1,089.80% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of XCUR is -1,940.20% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 5 years.
Exicure, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XCUR |
| CUSIP: | 30205M |
| Website: | exicuretx.com |
Debt
| Debt-to-Equity Ratio: | 0.05 |
|---|---|
| Current Ratio: | 1.96 |
| Quick Ratio: | 1.6 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XCUR Technical Analysis vs Fundamental Analysis
Sell
49
Exicure, Inc. (XCUR)
is a Sell
Is Exicure, Inc. a Buy or a Sell?
-
Exicure, Inc. stock is rated a SellThe current Exicure, Inc. [XCUR] share price is $5.92. The Score for XCUR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.